semaglutide abuse PDF) Is There a Risk for Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset Semaglutide versus placebo in individuals
Description
Marguet D, Baggio L, Kobayashi T, Bernard AM, Pierres M, Nielsen PF, Ribel U, Watanabe T, Drucker DJ, Wagtmann N (2000) Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26

Whilst it is associated with gastrointestinal side effects such as nausea and diarrhoea, leg cramps are not listed as a recognised adverse effect in UK prescribing information or clinical trial data

Gastrointestinal symptoms: The most frequently reported adverse effects of Ozempic involve the gastrointestinal system

While diabetes and obesity pose many of the same risks to the body, they arent exactly the same, so its hard to know whether that also influenced the results

Another potential GI benefit of semaglutide is its ability to reduce inflammation in the gut

In the previously mentioned case series, insulin therapy effectively improved glycaemic control
